SK

Sahitya Katikaneni

Senior Scientist II - CMC Formulation at ReCode Therapeutics

Sahitya Katikaneni has worked for four companies in their career. Sahitya began their professional career as a Summer Intern at Genencor in 2009. Sahitya then moved to Corium International as a Scientist II in 2011. In 2017, they joined Zosano Pharma as a Scientist III, Formulation & Process Development. Currently, they are employed at ReCode Therapeutics as a Senior Scientist II - CMC Formulation.

Sahitya Katikaneni obtained a Ph.D. in Pharmaceutical Sciences from Mercer University between 2005 and 2010.

Location

Menlo Park, United States

Links


Org chart

No direct reports

Teams


Offices


ReCode Therapeutics

1 followers

ReCode Therapeutics is an integrated genetic medicines company developing targeted, disease-modifying therapies for patients with life-limiting respiratory diseases.


Industries

Employees

51-200

Links